10,748 results on '"abatacept"'
Search Results
2. Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings
3. Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
4. Advancing Transplantation Outcomes in Children (ADVANTage)
5. Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
6. A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis
7. Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach
8. Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
9. Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction (BELASBRIDGE)
10. Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects
11. IL-2 Plus Abatacept in FTD
12. AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS (ACHLYS)
13. Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)
14. Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)
15. Study in ALS With Abatacept & IL-2
16. Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
17. Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes (IAA)
18. A Study of TCD601 in de Novo Renal Transplant Recipients (ASCEND)
19. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
20. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis.
21. Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
22. Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease (ABCVILD)
23. Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes (TN25)
24. Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination (VITAMIN)
25. Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO> (BELAFENDO)
26. Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
27. Belatacept in De Novo Heart Transplantation
28. Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
29. High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT) Study
30. Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
31. Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
32. Carfilzomib and Belatacept for Desensitization (ADAPT)
33. Daratumumab and Belatacept for Desensitization (ATTAIN)
34. Tolerance by Engaging Antigen During Cellular Homeostasis (TEACH)
35. Abatacept for the Treatment of Giant Cell Arteritis
36. Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis (ABA3)
37. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) (Limit-JIA)
38. Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
39. Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
40. Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA)
41. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
42. Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study.
43. MiR-155 regulates inflammatory responses and Th17/Treg imbalances in rheumatoid arthritis through the SOCS1/STAT3 pathway.
44. CCR4 predicts the efficacy of abatacept in rheumatoid arthritis patients through the estimation of Th17 and Treg cell abundance.
45. Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study.
46. Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis.
47. Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real‐world setting in Taiwan.
48. Luobitong Potentiates MTX's Anti-Rheumatoid Arthritis Activity via Targeting Multiple Inflammatory Pathways.
49. Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
50. Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.